Friday, November 24, 2017

Posts tagged with the keyword: ‘OXiGENE’

Oxigene Nears Marketing Approval of First Anaplastic Thyroid Cancer Drug

Oxigene Nears Marketing Approval of First Anaplastic Thyroid Cancer Drug

With just a few weeks left on the calendar before the world’s largest oncology annual meeting, investors are already gearing up their portfolios for equities that could see exponential gains based on their potentially new research abstracts. The American Society of Clinical Oncology (ASCO) will begin on June 3rd and will feature everything from investigational […]

FDA News: LifeVantage, OXiGENE, Pro-Pharmaceuticals, Regulus, SafeStitch, SonoSite, VIVUS

FDA News: LifeVantage, OXiGENE, Pro-Pharmaceuticals, Regulus, SafeStitch, SonoSite, VIVUS

The following companies made the news on Wednesday, June, 23, 2010 LifeVantage Corporation (OTC:LFVN) announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of Protandim┬« on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males. Symptoms usually appear […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo